Key Insights

Highlights

Treatment Research

1 treatments under study, led by Nouveal Numeric Application Onconect

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Nouveal Numeric Application Onconect1

Active Sponsors

  • Nouveal1
  • Assistance Publique - Hôpitaux de Paris1

Top Investigators

Related Conditions

  • Patient Reported Outcome Pro1
  • Compliance Treatment1
  • Adverse Event1
  • Oncology1
  • Care Telemonitoring1

Activity Timeline